Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intramuscular HBIG Grifols for Prevention of HBV Recurrence After Liver Transplant
NCT00895713Phase 2Completed
- Sponsor
- Grifols
- Start
- Nov 2004
- Primary completion
- Jun 2005
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of hepatitis B immune globulin in hepatitis B (HBV), sponsored by Grifols. Started Nov 2004; status: completed.
02
Drugs
hepatitis B immune globulin
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00895713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00895713.